Streetbeat News

Stock Prices

VEXTF

Vext Science, Inc. reported a challenging Q3 with an 11.8% drop in revenue to $8 million. Despite a year-over-year revenue increase of 5.5%, the company saw a significant decrease in gross profit and a net loss of $1.8 million. However, the company is optimistic about its expansion in Ohio's cannabis market, which is expected to grow to $4 billion in four years. Vext's stock traded lower after the report. The company remains focused on growth in Arizona and Ohio through 2024.

Portfolio Pulse from Jelena Martinovic

November 28, 2023 | 2:04 pm

BAC

COST

GLD

TGT

On CNBC's 'Halftime Report Final Trades,' analysts provided their recommendations on several stocks. Brian Belski of BMO Capital Markets highlighted Bank of America's (BAC) earnings and dividend yield. Costco (COST) was recommended by Jason Snipe, and Joseph Feldman maintained a $600 price target. Stephanie Link chose Target (TGT) after its strong quarterly results. Joseph Terranova selected SPDR Gold Shares (GLD) as gold prices rose. BAC shares fell, COST shares hit a new high, TGT shares slightly fell, and GLD shares gained.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 2:04 pm

ATNF

180 Life Sciences is reviewing strategic alternatives to enhance shareholder value. The company has not set a timeline for the completion of this review process.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:04 pm

CADL

Shares of Candel Therapeutics have been halted pending an announcement of news. Investors are awaiting the details of the news that prompted the trading halt.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:03 pm

ZS

Zscaler's stock price has declined following the release of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:03 pm

CMND

Clearmind Medicine shares have resumed trading. The company, possibly referenced as CMND in the article, had experienced a halt in trading prior to this announcement.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:02 pm

YY

JOYY (NASDAQ:YY) is expected to release its quarterly earnings report on Wednesday, 2023-11-29, with analysts predicting an EPS of $0.69. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, JOYY has had mixed reactions to earnings reports, with share price movements ranging from a 0.38% increase to a 7.84% decrease the day after earnings announcements. Shares are currently trading at $39.33, up 29.12% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 2:02 pm

YOSH

Yoshiharu Global Shares (YOSH) have resumed trading after a temporary halt. The article does not provide details on the reasons for the halt or the impact on the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:02 pm

FTCH

Farfetch (NYSE:FTCH) is scheduled to release its quarterly earnings report on Wednesday, 2023-11-29, with an estimated EPS of $-0.14. Investors are looking for an earnings beat and positive guidance for the next quarter. Despite beating EPS last quarter, FTCH's stock dropped 45.17% the following day. Over the past year, FTCH shares have declined by 79.65%, indicating potential dissatisfaction among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 2:01 pm

SEEL

Seelos Therapeutics shares have resumed trading after a temporary halt. The resumption of trading allows investors to buy and sell Seelos shares again, potentially impacting the stock's volatility and price in the short term.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:01 pm